{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:51:04Z","timestamp":1793141464016,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s40123-013-0019-y","type":"journal-article","created":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T05:57:54Z","timestamp":1378447074000},"page":"73-88","source":"Crossref","is-referenced-by-count":89,"title":["Management of Vernal Keratoconjunctivitis"],"prefix":"10.1007","volume":"2","author":[{"given":"Andrea","family":"Leonardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,7]]},"reference":[{"issue":"11","key":"19_CR1","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/all.12009","volume":"67","author":"A Leonardi","year":"2012","unstructured":"Leonardi A, Bogacka E, Fauquert JL, et al. Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface. Allergy. 2012;67(11):1327\u201337.","journal-title":"Allergy"},{"issue":"3","key":"19_CR2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1350-9462(02)00006-X","volume":"21","author":"A Leonardi","year":"2002","unstructured":"Leonardi A. Vernal keratoconjunctivitis: pathogenesis and treatment. Prog Retin Eye Res. 2002;21(3):319\u201339.","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"19_CR3","first-page":"88","volume":"34","author":"KF Tabbara","year":"1999","unstructured":"Tabbara KF. Ocular complications of vernal keratoconjunctivitis. Can J Ophthalmol. 1999;34(2):88\u201392.","journal-title":"Can J Ophthalmol"},{"issue":"6","key":"19_CR4","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0161-6420(00)00092-0","volume":"107","author":"S Bonini","year":"2000","unstructured":"Bonini S, Lambiase A, Marchi S, et al. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup. Ophthalmology. 2000;107(6):1157\u201363.","journal-title":"Ophthalmology"},{"issue":"5","key":"19_CR5","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1398-9995.2008.01858.x","volume":"64","author":"A Leonardi","year":"2009","unstructured":"Leonardi A, Sathe S, Bortolotti M, et al. Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients. Allergy. 2009;64(5):710\u20137.","journal-title":"Allergy"},{"issue":"10","key":"19_CR6","first-page":"1419","volume":"17","author":"AM Zicari","year":"2013","unstructured":"Zicari AM, Nebbioso M, Lollobrigida V, et al. Vernal keratoconjunctivitis: atopy and autoimmunity. Eur Rev Med Pharmacol Sci. 2013;17(10):1419\u201323.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"9","key":"19_CR7","first-page":"1242","volume":"17","author":"AM Zicari","year":"2013","unstructured":"Zicari AM, Nebbioso M, Zicari A, et al. Serum levels of IL-17 in patients with vernal keratoconjunctivitis: a preliminary report. Eur Rev Med Pharmacol Sci. 2013;17(9):1242\u20134.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"19_CR8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.preteyeres.2005.09.002","volume":"25","author":"N Kumagai","year":"2006","unstructured":"Kumagai N, Fukuda K, Fujitsu Y, et al. Role of structural cells of the cornea and conjunctiva in the pathogenesis of vernal keratoconjunctivitis. Prog Retin Eye Res. 2006;25(2):165\u201387.","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"19_CR9","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ajo.2012.11.018","volume":"155","author":"A Leonardi","year":"2013","unstructured":"Leonardi A, Lazzarini D, Motterle L, et al. Vernal keratoconjunctivitis-like disease in adults. Am J Ophthalmol. 2013;155(5):796\u2013803.","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"19_CR10","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/bjo.2007.122044","volume":"91","author":"F Mantelli","year":"2007","unstructured":"Mantelli F, Santos MS, Petitti T, et al. Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis. Br J Ophthalmol. 2007;91(12):1656\u201361.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"19_CR11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11882-010-0101-7","volume":"10","author":"S Kumar","year":"2010","unstructured":"Kumar S, Gupta N, Vivian AJ. Modern approach to managing vernal keratoconjunctivitis. Curr Allergy Asthma Rep. 2010;10(3):155\u201362.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"12","key":"19_CR12","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1001\/archopht.1977.04450120090009","volume":"95","author":"KF Tabbara","year":"1977","unstructured":"Tabbara KF, Arafat NT. Cromolyn effects on vernal keratoconjunctivitis in children. Arch Ophthalmol. 1977;95(12):2184\u20136.","journal-title":"Arch Ophthalmol"},{"issue":"Pt 6","key":"19_CR13","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/eye.1992.139","volume":"6","author":"S Bonini","year":"1992","unstructured":"Bonini S, Barney NP, Schiavone M, et al. Effectiveness of nedocromil sodium 2% eyedrops on clinical symptoms and tear fluid cytology of patients with vernal conjunctivitis. Eye. 1992;6(Pt 6):648\u201352.","journal-title":"Eye"},{"issue":"6","key":"19_CR14","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0002-9394(14)74786-5","volume":"113","author":"DR Caldwell","year":"1992","unstructured":"Caldwell DR, Verin P, Hartwich-Young R, et al. Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal keratoconjunctivitis. Am J Ophthalmol. 1992;113(6):632\u20137.","journal-title":"Am J Ophthalmol"},{"issue":"21 Suppl","key":"19_CR15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1398-9995.1995.tb04252.x","volume":"50","author":"NI Kjellman","year":"1995","unstructured":"Kjellman NI, Stevens MT. Clinical experience with Tilavist: an overview of efficacy and safety. Allergy. 1995;50(21 Suppl):14\u201322 (discussion 34\u20138).","journal-title":"Allergy"},{"issue":"5","key":"19_CR16","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0161-6420(97)30223-1","volume":"104","author":"S Bonini","year":"1997","unstructured":"Bonini S, Schiavone M, Magrini L, et al. Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis. Ophthalmology. 1997;104(5):849\u201353.","journal-title":"Ophthalmology"},{"issue":"1","key":"19_CR17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/bjo.81.1.23","volume":"81","author":"A Leonardi","year":"1997","unstructured":"Leonardi A, Borghesan F, Avarello A, et al. Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis. Br J Ophthalmol. 1997;81(1):23\u20136.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"19_CR18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000236823","volume":"105","author":"PM Cerqueti","year":"1994","unstructured":"Cerqueti PM, Ricca V, Tosca MA, et al. Lodoxamide treatment of allergic conjunctivitis. Int Arch Allergy Immunol. 1994;105(2):185\u20139.","journal-title":"Int Arch Allergy Immunol"},{"issue":"2","key":"19_CR19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000267878","volume":"28","author":"K Gunduz","year":"1996","unstructured":"Gunduz K, Ucakhan O, Budak K, et al. Efficacy of lodoxamide 0.1% versus N-acetyl aspartyl glutamic acid 6% ophthalmic solutions in patients with vernal keratoconjunctivitis. Ophthalmic Res. 1996;28(2):80\u20137.","journal-title":"Ophthalmic Res"},{"issue":"12","key":"19_CR20","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/bjo.2007.117515","volume":"91","author":"A Leonardi","year":"2007","unstructured":"Leonardi A, Bremond-Gignac D, Bortolotti M, et al. Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in vernal keratoconjunctivitis patients. Br J Ophthalmol. 2007;91(12):1662\u20136.","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"19_CR21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/02713688608996374","volume":"5","author":"P Lapalus","year":"1986","unstructured":"Lapalus P, Moulin G, Bayer V, et al. Effects of a new anti-allergic agent: the magnesium salt of N-acetyl-aspartyl-glutamic acid on experimental allergic inflammation of the rabbit eye. Curr Eye Res. 1986;5(7):517\u201322.","journal-title":"Curr Eye Res"},{"issue":"5","key":"19_CR22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/01.all.0000183113.63311.11","volume":"5","author":"L Bielory","year":"2005","unstructured":"Bielory L, Ghafoor S. Histamine receptors and the conjunctiva. Curr Opin Allergy Clin Immunol. 2005;5(5):437\u201340.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"5","key":"19_CR23","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/archopht.117.5.643","volume":"117","author":"JM Yanni","year":"1999","unstructured":"Yanni JM, Weimer LK, Sharif NA, et al. Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs. Arch Ophthalmol. 1999;117(5):643\u20137.","journal-title":"Arch Ophthalmol"},{"key":"19_CR24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1600-0420.1999.tb01171.x","volume":"228","author":"JM Yanni","year":"1999","unstructured":"Yanni JM, Sharif NA, Gamache DA, et al. A current appreciation of sites for pharmacological intervention in allergic conjunctivitis: effects of new topical ocular drugs. Acta Ophthalmol Scand Suppl. 1999;228:33\u20137.","journal-title":"Acta Ophthalmol Scand Suppl"},{"issue":"2","key":"19_CR25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/112067210101100203","volume":"11","author":"P Verin","year":"2001","unstructured":"Verin P, Allewaert R, Joyaux JC, et al. Comparison of lodoxamide 0.1% ophthalmic solution and levocabastine 0.05% ophthalmic suspension in vernal keratoconjunctivitis. Eur J Ophthalmol. 2001;11(2):120\u20135.","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"19_CR26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.bcp.2008.07.007","volume":"76","author":"AR Qasem","year":"2008","unstructured":"Qasem AR, Bucolo C, Baiula M, et al. Contribution of alpha4beta1 integrin to the antiallergic effect of levocabastine. Biochem Pharmacol. 2008;76(6):751\u201362.","journal-title":"Biochem Pharmacol"},{"key":"19_CR27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1034\/j.1600-0420.2000.078s230048.x","volume":"230","author":"A Secchi","year":"2000","unstructured":"Secchi A, Leonardi A, Discepola M, et al. An efficacy and tolerance comparison of emedastine difumarate 0.05% and levocabastine hydrochloride 0.05%: reducing chemosis and eyelid swelling in subjects with seasonal allergic conjunctivitis. Emadine Study Group. Acta Ophthalmol Scand Suppl. 2000;230:48\u201351.","journal-title":"Acta Ophthalmol Scand Suppl"},{"key":"19_CR28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1034\/j.1600-0420.2000.078s230042.x","volume":"230","author":"A Secchi","year":"2000","unstructured":"Secchi A, Ciprandi G, Leonardi A, et al. Safety and efficacy comparison of emedastine 0.05% ophthalmic solution compared to levocabastine 0.05% ophthalmic suspension in pediatric subjects with allergic conjunctivitis. Emadine Study Group. Acta Ophthalmol Scand Suppl. 2000;230:42\u20137.","journal-title":"Acta Ophthalmol Scand Suppl"},{"issue":"6","key":"19_CR29","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1590\/S0004-27492006000600013","volume":"69","author":"WT Hida","year":"2006","unstructured":"Hida WT, Nogueira DC, Schaefer A, et al. Comparative study between 0.025% ketotifen fumarate and 0.1% olopatadine hydrochloride in the treatment of vernal keratoconjunctivitis. Arq Bras Oftalmol. 2006;69(6):851\u20136.","journal-title":"Arq Bras Oftalmol"},{"issue":"5","key":"19_CR30","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1089\/jop.2005.21.400","volume":"21","author":"I Corum","year":"2005","unstructured":"Corum I, Yeniad B, Bilgin LK, Ilhan R. Efficiency of olopatadine hydrochloride 0.1% in the treatment of vernal keratoconjunctivitis and goblet cell density. J Ocul Pharmacol Ther. 2005;21(5):400\u20135.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"19_CR31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0091-6749(94)90081-7","volume":"94","author":"SL Spector","year":"1994","unstructured":"Spector SL, Raizman MB. Conjunctivitis medicamentosa. J Allergy Clin Immunol. 1994;94(1):134\u20136.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"19_CR32","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1136\/bjo.84.11.1228","volume":"84","author":"A Leonardi","year":"2000","unstructured":"Leonardi A, Busato F, Fregona I, et al. Anti-inflammatory and antiallergic effects of ketorolac tromethamine in the conjunctival provocation model. Br J Ophthalmol. 2000;84(11):1228\u201332.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"19_CR33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1755-3768.1991.tb02000.x","volume":"69","author":"S Gupta","year":"1991","unstructured":"Gupta S, Khurana AK, Ahluwalia BK, Gupta NC. Topical indomethacin for vernal keratoconjunctivitis. Acta Ophthalmol (Copenh). 1991;69(1):95\u20138.","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"3","key":"19_CR34","first-page":"177","volume":"45","author":"A Sharma","year":"1997","unstructured":"Sharma A, Gupta R, Ram J, Gupta A. Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis. Indian J Ophthalmol. 1997;45(3):177\u201380.","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"19_CR35","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00417-002-0612-6","volume":"241","author":"G D\u2019Angelo","year":"2003","unstructured":"D\u2019Angelo G, Lambiase A, Cortes M, et al. Preservative-free diclofenac sodium 0.1% for vernal keratoconjunctivitis. Graefes Arch Clin Exp Ophthalmol. 2003;241(3):192\u20135.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"19_CR36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-200225010-00004","volume":"25","author":"CN McGhee","year":"2002","unstructured":"McGhee CN, Dean S, Danesh-Meyer H. Locally administered ocular corticosteroids: benefits and risks. Drug Saf. 2002;25(1):33\u201355.","journal-title":"Drug Saf"},{"key":"19_CR37","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2147\/OPTH.S32936","volume":"6","author":"M Ang","year":"2012","unstructured":"Ang M, Ti SE, Loh R, et al. Steroid-induced ocular hypertension in Asian children with severe vernal keratoconjunctivitis. Clin Ophthalmol. 2012;6:1253\u20138.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"19_CR38","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1111\/j.1442-9071.2011.02591.x","volume":"40","author":"M Ang","year":"2012","unstructured":"Ang M, Ho CL, Tan D, Chan C. Severe vernal keratoconjunctivitis requiring trabeculectomy with mitomycin C for corticosteroid-induced glaucoma. Clin Exp Ophthalmol. 2012;40(4):e149\u201355.","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"19_CR39","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3109\/09273948.2010.498657","volume":"18","author":"CA Utine","year":"2010","unstructured":"Utine CA, Stern M, Akpek EK. Clinical review: topical ophthalmic use of cyclosporin A. Ocul Immunol Inflamm. 2010;18(5):352\u201361.","journal-title":"Ocul Immunol Inflamm"},{"key":"19_CR40","doi-asserted-by":"crossref","unstructured":"Lambiase A, Leonardi A, Sacchetti M, et al. Topical cyclosporine prevents seasonal recurrences of vernal keratoconjunctivitis in a randomized, double-masked, controlled 2-year study. J Allergy Clin Immunol. 2011;128(4):896\u20137 e9.","DOI":"10.1016\/j.jaci.2011.07.004"},{"issue":"3","key":"19_CR41","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1081-1206(10)61958-8","volume":"89","author":"N Pucci","year":"2002","unstructured":"Pucci N, Novembre E, Cianferoni A, et al. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis. Ann Allergy Asthma Immunol. 2002;89(3):298\u2013303.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"19_CR42","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1398-9995.1995.tb01209.x","volume":"50","author":"A Leonardi","year":"1995","unstructured":"Leonardi A, Borghesan F, Faggian D, et al. Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis. Allergy. 1995;50(7):610\u20133.","journal-title":"Allergy"},{"issue":"2","key":"19_CR43","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00003226-200403000-00014","volume":"23","author":"A Cetinkaya","year":"2004","unstructured":"Cetinkaya A, Akova YA, Dursun D, Pelit A. Topical cyclosporine in the management of shield ulcers. Cornea. 2004;23(2):194\u2013200.","journal-title":"Cornea"},{"issue":"4","key":"19_CR44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/bjo.2005.082461","volume":"90","author":"M Daniell","year":"2006","unstructured":"Daniell M, Constantinou M, Vu HT, Taylor HR. Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis. Br J Ophthalmol. 2006;90(4):461\u20134.","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"19_CR45","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/ICO.0b013e31812dfab3","volume":"26","author":"AA Ozcan","year":"2007","unstructured":"Ozcan AA, Ersoz TR, Dulger E. Management of severe allergic conjunctivitis with topical cyclosporin a 0.05% eyedrops. Cornea. 2007;26(9):1035\u20138.","journal-title":"Cornea"},{"issue":"4","key":"19_CR46","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/jop.2008.0103","volume":"25","author":"N Ebihara","year":"2009","unstructured":"Ebihara N, Ohashi Y, Uchio E, et al. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis. J Ocul Pharmacol Ther. 2009;25(4):365\u201372.","journal-title":"J Ocul Pharmacol Ther"},{"key":"19_CR47","doi-asserted-by":"crossref","unstructured":"Wan KH, Chen LJ, Rong SS, et al. Topical Cyclosporine in the Treatment of Allergic Conjunctivitis: A Meta-analysis. Ophthalmology. 2013.","DOI":"10.1016\/j.ophtha.2013.03.044"},{"issue":"3","key":"19_CR48","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0002-9394(02)01982-7","volume":"135","author":"SM Rikkers","year":"2003","unstructured":"Rikkers SM, Holland GN, Drayton GE, et al. Topical tacrolimus treatment of atopic eyelid disease. Am J Ophthalmol. 2003;135(3):297\u2013302.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"19_CR49","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jaci.2003.10.065","volume":"113","author":"P Vichyanond","year":"2004","unstructured":"Vichyanond P, Tantimongkolsuk C, Dumrongkigchaiporn P, et al. Vernal keratoconjunctivitis: result of a novel therapy with 0.1% topical ophthalmic FK-506 ointment. J Allergy Clin Immunol. 2004;113(2):355\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"19_CR50","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1600-0420.2006.00699.x","volume":"84","author":"HM Virtanen","year":"2006","unstructured":"Virtanen HM, Reitamo S, Kari M, Kari O. Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study. Acta Ophthalmol Scand. 2006;84(5):693\u20135.","journal-title":"Acta Ophthalmol Scand"},{"issue":"7","key":"19_CR51","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/02713680802149115","volume":"33","author":"L Attas-Fox","year":"2008","unstructured":"Attas-Fox L, Barkana Y, Iskhakov V, et al. Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study. Curr Eye Res. 2008;33(7):545\u20139.","journal-title":"Curr Eye Res"},{"issue":"2","key":"19_CR52","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/jop.2009.0087","volume":"26","author":"Y Ohashi","year":"2010","unstructured":"Ohashi Y, Ebihara N, Fujishima H, et al. A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis. J Ocul Pharmacol Ther. 2010;26(2):165\u201374.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"19_CR53","first-page":"177","volume":"30","author":"P Labcharoenwongs","year":"2012","unstructured":"Labcharoenwongs P, Jirapongsananuruk O, Visitsunthorn N, et al. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children. Asian Pac J Allergy Immunol. 2012;30(3):177\u201384.","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"2","key":"19_CR54","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0161-6420(99)00096-2","volume":"107","author":"EK Akpek","year":"2000","unstructured":"Akpek EK, Hasiripi H, Christen WG, Kalayci D. A randomized trial of low-dose, topical mitomycin-C in the treatment of severe vernal keratoconjunctivitis. Ophthalmology. 2000;107(2):263\u20139.","journal-title":"Ophthalmology"},{"issue":"3","key":"19_CR55","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S1081-1206(10)60453-X","volume":"100","author":"L Bielory","year":"2008","unstructured":"Bielory L. Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal corticosteroid mometasone furoate. Ann Allergy Asthma Immunol. 2008;100(3):272\u20139.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"19_CR56","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.jaci.2009.03.015","volume":"123","author":"FM Baroody","year":"2009","unstructured":"Baroody FM, Shenaq D, DeTineo M, et al. Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. J Allergy Clin Immunol. 2009;123(6):1342\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"7173","key":"19_CR57","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1136\/bmj.317.7173.1624","volume":"317","author":"JM Weiner","year":"1998","unstructured":"Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ. 1998;317(7173):1624\u20139.","journal-title":"BMJ"},{"issue":"2","key":"19_CR58","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003495-200565020-00004","volume":"65","author":"L Bielory","year":"2005","unstructured":"Bielory L, Lien KW, Bigelsen S. Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis. Drugs. 2005;65(2):215\u201328.","journal-title":"Drugs"},{"issue":"2","key":"19_CR59","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2165\/00003495-199550020-00002","volume":"50","author":"M Hingorani","year":"1995","unstructured":"Hingorani M, Lightman S. Therapeutic options in ocular allergic disease. Drugs. 1995;50(2):208\u201321.","journal-title":"Drugs"},{"issue":"4","key":"19_CR60","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0002-9394(83)90272-6","volume":"95","author":"MB Abelson","year":"1983","unstructured":"Abelson MB, Butrus SI, Weston JH. Aspirin therapy in vernal conjunctivitis. Am J Ophthalmol. 1983;95(4):502\u20135.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"19_CR61","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/ICO.0b013e318172fbb1","volume":"27","author":"F Anzaar","year":"2008","unstructured":"Anzaar F, Gallagher MJ, Bhat P, et al. Use of systemic T-lymphocyte signal transduction inhibitors in the treatment of atopic keratoconjunctivitis. Cornea. 2008;27(8):884\u20138.","journal-title":"Cornea"},{"key":"19_CR62","volume-title":"Biswas S","author":"TA Klerk de","year":"2013","unstructured":"de Klerk TA, Sharma V, Arkwright PD. Biswas S. J AAPOS: Severe vernal keratoconjunctivitis successfully treated with subcutaneous omalizumab; 2013."},{"issue":"9","key":"19_CR63","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1365-2222.2011.03835.x","volume":"41","author":"MA Calderon","year":"2011","unstructured":"Calderon MA, Penagos M, Sheikh A, et al. Sublingual immunotherapy for allergic conjunctivitis: Cochrane systematic review and meta-analysis. Clin Exp Allergy. 2011;41(9):1263\u201372.","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"19_CR64","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/ICO.0b013e3181eae270","volume":"31","author":"RA Mahdy","year":"2012","unstructured":"Mahdy RA, Nada WM, Marei AA. Subcutaneous allergen-specific immunotherapy versus topical treatment in vernal keratoconjunctivitis. Cornea. 2012;31(5):525\u20138.","journal-title":"Cornea"},{"issue":"3","key":"19_CR65","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0002-9394(14)70271-5","volume":"121","author":"DS Holsclaw","year":"1996","unstructured":"Holsclaw DS, Whitcher JP, Wong IG, Margolis TP. Supratarsal injection of corticosteroid in the treatment of refractory vernal keratoconjunctivitis. Am J Ophthalmol. 1996;121(3):243\u20139.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"19_CR66","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/00003226-200405000-00003","volume":"23","author":"M Tanaka","year":"2004","unstructured":"Tanaka M, Takano Y, Dogru M, et al. A comparative evaluation of the efficacy of intraoperative mitomycin C use after the excision of cobblestone-like papillae in severe atopic and vernal keratoconjunctivitis. Cornea. 2004;23(4):326\u20139.","journal-title":"Cornea"},{"issue":"5","key":"19_CR67","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0021-5155(00)00210-0","volume":"44","author":"H Fujishima","year":"2000","unstructured":"Fujishima H, Fukagawa K, Satake Y, et al. Combined medical and surgical treatment of severe vernal keratoconjunctivitis. Jpn J Ophthalmol. 2000;44(5):511\u20135.","journal-title":"Jpn J Ophthalmol"},{"issue":"3","key":"19_CR68","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/01.ico.0000183533.14899.8d","volume":"25","author":"M Tanaka","year":"2006","unstructured":"Tanaka M, Dogru M, Takano Y, et al. Quantitative evaluation of the early changes in ocular surface inflammation following MMC-aided papillary resection in severe allergic patients with corneal complications. Cornea. 2006;25(3):281\u20135.","journal-title":"Cornea"},{"issue":"6","key":"19_CR69","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0161-6420(95)30925-6","volume":"102","author":"JA Cameron","year":"1995","unstructured":"Cameron JA. Shield ulcers and plaques of the cornea in vernal keratoconjunctivitis. Ophthalmology. 1995;102(6):985\u201393.","journal-title":"Ophthalmology"},{"key":"19_CR70","doi-asserted-by":"crossref","unstructured":"Reddy JC, Basu S, Saboo US, et al. Management, clinical outcomes, and complications of shield ulcers in vernal keratoconjunctivitis. Am J Ophthalmol. 2013;155(3):550\u20139 e1.","DOI":"10.1016\/j.ajo.2012.09.014"},{"issue":"5","key":"19_CR71","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/ICO.0b013e3181cbf9d3","volume":"30","author":"VS Sangwan","year":"2011","unstructured":"Sangwan VS, Jain V, Vemuganti GK, Murthy SI. Vernal keratoconjunctivitis with limbal stem cell deficiency. Cornea. 2011;30(5):491\u20136.","journal-title":"Cornea"},{"issue":"4","key":"19_CR72","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/01.ico.0000151508.49565.8a","volume":"24","author":"VS Sangwan","year":"2005","unstructured":"Sangwan VS, Murthy SI, Vemuganti GK, et al. Cultivated corneal epithelial transplantation for severe ocular surface disease in vernal keratoconjunctivitis. Cornea. 2005;24(4):426\u201330.","journal-title":"Cornea"},{"issue":"7","key":"19_CR73","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.ophtha.2009.11.043","volume":"117","author":"M Sacchetti","year":"2010","unstructured":"Sacchetti M, Lambiase A, Mantelli F, et al. Tailored approach to the treatment of vernal keratoconjunctivitis. Ophthalmology. 2010;117(7):1294\u20139.","journal-title":"Ophthalmology"},{"key":"19_CR74","doi-asserted-by":"crossref","unstructured":"Leonardi A, Lazzarini D, Bortolotti M, et al. Corneal confocal microscopy in patients with vernal keratoconjunctivitis. Ophthalmology. 2011.","DOI":"10.1016\/j.ophtha.2011.09.018"},{"issue":"3","key":"19_CR75","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ophtha.2011.09.018","volume":"119","author":"A Leonardi","year":"2012","unstructured":"Leonardi A, Lazzarini D, Bortolotti M, et al. Corneal confocal microscopy in patients with vernal keratoconjunctivitis. Ophthalmology. 2012;119(3):509\u201315.","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-013-0019-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T09:32:06Z","timestamp":1563874326000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40123-013-0019-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,7]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["19"],"URL":"https:\/\/doi.org\/10.1007\/s40123-013-0019-y","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,7]]}}}